Viral miRNA-mediated activation of hyaluronan production as a drug target against COVID-19

被引：0
|
作者：
Shuai Yang [1 ,2 ]
Lu Chen [1 ,2 ]
Ying Tong [1 ,2 ]
Wenqiang Yu [1 ,2 ]
机构：
[1] Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences & Shanghai Public Health Clinical Center & Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute, Shanghai Medical College, Fudan University
[2] Shanghai Key Laboratory of Medical Epigenetics
来源：
ActaPharmaceuticaSinicaB | 2022年 / 12卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The global coronavirus disease 2019(COVID-19) pandemic has caused more than 6.1 million deaths until March 24, 2022, as reported by the World Health Organization(WHO). Recently,breakthrough infections have appeared in individuals fully vaccinated against SARS-Co V-21, which could be attributed to the rapid mutation of the RNA virus2. Currently, following the Delta variant, the Omicron variant of SARS-Co V-2 is increasingly becoming the dominant epidemic strain in the world.
引用
收藏
页码：3195 / 3197
页数：3
相关论文
共 50 条
  • [1] Viral miRNA-mediated activation of hyaluronan production as a drug target against COVID-19
    Yang, Shuai
    Chen, Lu
    Tong, Ying
    Yu, Wenqiang
    ACTA PHARMACEUTICA SINICA B, 2022, 12 (07) : 3195 - 3197
  • [2] Systems genetics identifies miRNA-mediated regulation of host response in COVID-19
    Gjorgjieva, T.
    Chaloemtoem, A.
    Shahin, T.
    Bayaraa, O.
    Dieng, M. M.
    Alshaikh, M.
    Abdalbaqi, M.
    Del Monte, J.
    Begum, G.
    Leonor, C.
    Manikandan, V.
    Drou, N.
    Arshad, M.
    Arnoux, M.
    Kumar, N.
    Jabari, A.
    Abdulle, A.
    ElGhazali, G.
    Ali, R.
    Shaheen, S. Y.
    Abdalla, J.
    Piano, F.
    Gunsalus, K. C.
    Daggag, H.
    Al Nahdi, H.
    Abuzeid, H.
    Idaghdour, Y.
    HUMAN GENOMICS, 2023, 17 (01)
  • [3] Systems genetics identifies miRNA-mediated regulation of host response in COVID-19
    T. Gjorgjieva
    A. Chaloemtoem
    T. Shahin
    O. Bayaraa
    M. M. Dieng
    M. Alshaikh
    M. Abdalbaqi
    J. Del Monte
    G. Begum
    C. Leonor
    V. Manikandan
    N. Drou
    M. Arshad
    M. Arnoux
    N. Kumar
    A. Jabari
    A. Abdulle
    G. ElGhazali
    R. Ali
    S. Y. Shaheen
    J. Abdalla
    F. Piano
    K. C. Gunsalus
    H. Daggag
    H. Al Nahdi
    H. Abuzeid
    Y. Idaghdour
    Human Genomics, 17
  • [4] Viral targets for vaccines against COVID-19
    Lianpan Dai
    George F. Gao
    Nature Reviews Immunology, 2021, 21 : 73 - 82
  • [5] Viral targets for vaccines against COVID-19
    Dai, Lianpan
    Gao, George F.
    NATURE REVIEWS IMMUNOLOGY, 2021, 21 (02) : 73 - 82
  • [6] Network neighbors of viral targets and differentially expressed genes in COVID-19 are drug target candidates
    Zambrana, Carme
    Xenos, Alexandros
    Bottcher, Rene
    Malod-Dognin, Noel
    Przulj, Natasa
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [7] Network neighbors of viral targets and differentially expressed genes in COVID-19 are drug target candidates
    Carme Zambrana
    Alexandros Xenos
    René Böttcher
    Noël Malod-Dognin
    Nataša Pržulj
    Scientific Reports, 11
  • [8] Remdesivir against COVID-19 and Other Viral Diseases
    Malin, Jakob J.
    Suarez, Isabelle
    Priesner, Vanessa
    Fatkenheuer, Gerd
    Rybniker, Jan
    CLINICAL MICROBIOLOGY REVIEWS, 2021, 34 (01) : 1 - 21
  • [9] Molnupiravir: an antiviral drug against COVID-19
    Dave, Bhavarth
    Shah, Kashvi C.
    Chorawala, Mehul R.
    Shah, Nirav
    Patel, Pranjal
    Patel, Suzan
    Shah, Palak
    ARCHIVES OF VIROLOGY, 2023, 168 (10)
  • [10] Molnupiravir: an antiviral drug against COVID-19
    Bhavarth Dave
    Kashvi C. Shah
    Mehul R. Chorawala
    Nirav Shah
    Pranjal Patel
    Suzan Patel
    Palak Shah
    Archives of Virology, 2023, 168
12345